Global drug deal announced

Two global drug companies have plans to “become a leader in specialty pharma” through a transaction valued at $6.8 billion.

Teva Pharmaceutical Industries Ltd. announced on May 2 that it plans...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

Try FTCWatch FREE for 30 days
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch
Current Issue: 1029
Next Issue: Jul 12, 2022

Browse Archives

Current Issue

In this Issue:


RSS Feed
Print